Related references
Note: Only part of the references are listed.Parkinson's disease dementia: a neural networks perspective
James Gratwicke et al.
BRAIN (2015)
Mild Cognitive Impairment and Parkinson's Disease - Something to Remember
Roger A. Barker et al.
JOURNAL OF PARKINSONS DISEASE (2014)
Aldehyde dehydrogenase variation enhances effect of pesticides associated with Parkinson disease
Arthur G. Fitzmaurice et al.
NEUROLOGY (2014)
Ensembl 2014
Paul Flicek et al.
NUCLEIC ACIDS RESEARCH (2014)
Noradrenergic modulation of cognition: Therapeutic implications
Samuel R. Chamberlain et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2013)
Aldehyde dehydrogenase inhibition as a pathogenic mechanism in Parkinson disease
Arthur G. Fitzmaurice et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Neuropsychological profile in patients with early stage of Parkinson's disease in Taiwan
Rwei-Ling Yu et al.
PARKINSONISM & RELATED DISORDERS (2012)
Meta-Analysis of Aldehyde Dehydrogenase 2 Gene Polymorphism and Alzheimer's Disease in East Asians
Pan-Pan Hao et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2011)
Mild Cognitive Impairment in Parkinson's Disease
Dag Aarsland et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2011)
The Economic Impact of Cognitive Impairment in Parkinson's Disease
Corinna Vossius et al.
MOVEMENT DISORDERS (2011)
Impulsivity, Compulsivity, and Top-Down Cognitive Control
Jeffrey W. Dalley et al.
NEURON (2011)
Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease
Angie A. Kehagia et al.
LANCET NEUROLOGY (2010)
Systematic Review of Levodopa Dose Equivalency Reporting in Parkinson's Disease
Claire L. Tomlinson et al.
MOVEMENT DISORDERS (2010)
Cognitive Impairment in Parkinson's Disease: Tools for Diagnosis and Assessment
Jaime Kulisevsky et al.
MOVEMENT DISORDERS (2009)
Cognitive impairment in incident, untreated Parkinson disease The Norwegian ParkWest Study
D. Aarsland et al.
NEUROLOGY (2009)
The Dopamine Hypothesis of Schizophrenia: Version III - The Final Common Pathway
Oliver D. Howes et al.
SCHIZOPHRENIA BULLETIN (2009)
The Alcohol Flushing Response: An Unrecognized Risk Factor for Esophageal Cancer from Alcohol Consumption
Philip J. Brooks et al.
PLOS MEDICINE (2009)
Dementia in Parkinson's disease
Dag Aarsland et al.
CURRENT OPINION IN NEUROLOGY (2008)
Dementia and survival in Parkinson disease - A 12-year population study
T. C. Buter et al.
NEUROLOGY (2008)
Clinical diagnostic criteria for dementia associated with Parkinson's disease
Murat Emre et al.
MOVEMENT DISORDERS (2007)
Neurotoxicity and metabolism of the catecholamine-derived 3,4-dihydroxyphenylacetaldehyde and 3,4-dihydroxyphenylglycolaldehyde: The role of aldehyde dehydrogenase
Satori A. Marchitti et al.
PHARMACOLOGICAL REVIEWS (2007)
Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030
E. R. Dorsey et al.
NEUROLOGY (2007)
A systematic review of prevalence studies of dementia in Parkinson's disease
D Aarsland et al.
MOVEMENT DISORDERS (2005)
World Health Organization/International Society for Biomedical Research on Alcoholism study on state and trait markers of alcohol use and dependence:: Back to the future
FM Wurst et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2005)
Catecholamine metabolism: A contemporary view with implications for physiology and medicine
G Eisenhofer et al.
PHARMACOLOGICAL REVIEWS (2004)
Neurotoxicity of MAO metabolites of catecholamine neurotransmitters: Role in neurodegenerative diseases
WJ Burke et al.
NEUROTOXICOLOGY (2004)
Cognitive and SPECT characteristics predict progression of Parkinson's disease in newly diagnosed patients
K Dujardin et al.
JOURNAL OF NEUROLOGY (2004)
Executive functions and their disorders
R Elliott
BRITISH MEDICAL BULLETIN (2003)
3,4-Dihydroxyphenylacetaldehyde and hydrogen peroxide generate a hydroxyl radical: possible role in Parkinson's disease pathogenesis
SW Li et al.
MOLECULAR BRAIN RESEARCH (2001)
Selective dopaminergic vulnerability: 3,4-dihydroxyphenylacetaldehyde targets mitochondria
BS Kristal et al.
FREE RADICAL BIOLOGY AND MEDICINE (2001)
Risk of dementia in Parkinson's disease - A community-based, prospective study
D Aarsland et al.
NEUROLOGY (2001)
Alcohol and aldehyde dehydrogenase gene polymorphisms and oropharyngolaryngeal, esophageal and stomach cancers in Japanese alcoholics
A Yokoyama et al.
CARCINOGENESIS (2001)
Deficiency in mitochondrial aldehyde dehydrogenase increases the risk for late-onset Alzheimer's disease in the Japanese population
K Kamino et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
3,4-Dihydroxyphenylacetaldehyde potentiates the toxic effects of metabolic stress in PC12 cells
I Lamensdorf et al.
BRAIN RESEARCH (2000)
What contributes to quality of life in patients with Parkinson's disease?
A Schrag et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2000)
Macular microcirculation characteristics in Parkinson's disease evaluated by OCT-Angiography: a literature review
Evita Evangelia Christou et al.
SEMINARS IN OPHTHALMOLOGY
Share Paper
